Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Isis Trading Halts as FDA Reviews Key Drug's Risks
Isis Trading Halts as FDA Reviews Key Drug's Risks
Isis Trading Halts as FDA Reviews Key Drug's Risks
Submitted by
admin
on October 20, 2012 - 10:49am
Source:
PharmPro
News Tags:
Isis Pharmaceuticals
Kynamro
hypercholesterolemia
Headline:
Isis Trading Halts as FDA Reviews Key Drug's Risks
Do Not Allow Advertisers to Use My Personal information
